<?xml version='1.0' encoding='utf-8'?>
<document id="24956178"><sentence text="In vitro and in silico studies to explore structural features of flavonoids for aldehyde oxidase inhibition."><entity charOffset="65-75" id="DDI-PubMed.24956178.s1.e0" text="flavonoids" /><entity charOffset="80-88" id="DDI-PubMed.24956178.s1.e1" text="aldehyde" /><pair ddi="false" e1="DDI-PubMed.24956178.s1.e0" e2="DDI-PubMed.24956178.s1.e0" /><pair ddi="false" e1="DDI-PubMed.24956178.s1.e0" e2="DDI-PubMed.24956178.s1.e1" /></sentence><sentence text="Aldehyde oxidase (AO), an important enzyme in the biotransformation of drugs and xenobiotics, is inhibited by flavonoids"><entity charOffset="0-8" id="DDI-PubMed.24956178.s2.e0" text="Aldehyde" /><entity charOffset="110-120" id="DDI-PubMed.24956178.s2.e1" text="flavonoids" /><pair ddi="false" e1="DDI-PubMed.24956178.s2.e0" e2="DDI-PubMed.24956178.s2.e0" /><pair ddi="false" e1="DDI-PubMed.24956178.s2.e0" e2="DDI-PubMed.24956178.s2.e1" /></sentence><sentence text=" This enzyme can metabolize both aldehydes and N-heterocycles"><entity charOffset="33-42" id="DDI-PubMed.24956178.s3.e0" text="aldehydes" /><entity charOffset="47-61" id="DDI-PubMed.24956178.s3.e1" text="N-heterocycles" /><pair ddi="false" e1="DDI-PubMed.24956178.s3.e0" e2="DDI-PubMed.24956178.s3.e0" /><pair ddi="false" e1="DDI-PubMed.24956178.s3.e0" e2="DDI-PubMed.24956178.s3.e1" /></sentence><sentence text=" In this work, a set of 15 flavonoids was assessed for inhibitory activity on the AO oxidation of vanillin as an aldehyde substrate"><entity charOffset="27-37" id="DDI-PubMed.24956178.s4.e0" text="flavonoids" /><entity charOffset="98-106" id="DDI-PubMed.24956178.s4.e1" text="vanillin" /><entity charOffset="113-121" id="DDI-PubMed.24956178.s4.e2" text="aldehyde" /><pair ddi="false" e1="DDI-PubMed.24956178.s4.e0" e2="DDI-PubMed.24956178.s4.e0" /><pair ddi="false" e1="DDI-PubMed.24956178.s4.e0" e2="DDI-PubMed.24956178.s4.e1" /><pair ddi="false" e1="DDI-PubMed.24956178.s4.e0" e2="DDI-PubMed.24956178.s4.e2" /><pair ddi="false" e1="DDI-PubMed.24956178.s4.e1" e2="DDI-PubMed.24956178.s4.e1" /><pair ddi="false" e1="DDI-PubMed.24956178.s4.e1" e2="DDI-PubMed.24956178.s4.e2" /></sentence><sentence text=" Spectrophotometrically determined IC50 values showed that myricetin, quercetin, and epicatechin were the most potent inhibitors"><entity charOffset="59-68" id="DDI-PubMed.24956178.s5.e0" text="myricetin" /><entity charOffset="70-79" id="DDI-PubMed.24956178.s5.e1" text="quercetin" /><entity charOffset="85-96" id="DDI-PubMed.24956178.s5.e2" text="epicatechin" /><pair ddi="false" e1="DDI-PubMed.24956178.s5.e0" e2="DDI-PubMed.24956178.s5.e0" /><pair ddi="false" e1="DDI-PubMed.24956178.s5.e0" e2="DDI-PubMed.24956178.s5.e1" /><pair ddi="false" e1="DDI-PubMed.24956178.s5.e0" e2="DDI-PubMed.24956178.s5.e2" /><pair ddi="false" e1="DDI-PubMed.24956178.s5.e1" e2="DDI-PubMed.24956178.s5.e1" /><pair ddi="false" e1="DDI-PubMed.24956178.s5.e1" e2="DDI-PubMed.24956178.s5.e2" /></sentence><sentence text=" The results also revealed that the inhibition of vanillin oxidation by flavonoids was stronger than that of phenanthridine oxidation (an N-heterocyclic substrate) as reported previously"><entity charOffset="50-58" id="DDI-PubMed.24956178.s6.e0" text="vanillin" /><entity charOffset="72-82" id="DDI-PubMed.24956178.s6.e1" text="flavonoids" /><entity charOffset="109-123" id="DDI-PubMed.24956178.s6.e2" text="phenanthridine" /><entity charOffset="138-152" id="DDI-PubMed.24956178.s6.e3" text="N-heterocyclic" /><pair ddi="false" e1="DDI-PubMed.24956178.s6.e0" e2="DDI-PubMed.24956178.s6.e0" /><pair ddi="false" e1="DDI-PubMed.24956178.s6.e0" e2="DDI-PubMed.24956178.s6.e1" /><pair ddi="false" e1="DDI-PubMed.24956178.s6.e0" e2="DDI-PubMed.24956178.s6.e2" /><pair ddi="false" e1="DDI-PubMed.24956178.s6.e0" e2="DDI-PubMed.24956178.s6.e3" /><pair ddi="false" e1="DDI-PubMed.24956178.s6.e1" e2="DDI-PubMed.24956178.s6.e1" /><pair ddi="false" e1="DDI-PubMed.24956178.s6.e1" e2="DDI-PubMed.24956178.s6.e2" /><pair ddi="false" e1="DDI-PubMed.24956178.s6.e1" e2="DDI-PubMed.24956178.s6.e3" /><pair ddi="false" e1="DDI-PubMed.24956178.s6.e2" e2="DDI-PubMed.24956178.s6.e2" /><pair ddi="false" e1="DDI-PubMed.24956178.s6.e2" e2="DDI-PubMed.24956178.s6.e3" /></sentence><sentence text=" In order to investigate the important structural features responsible for the inhibitory effects of the studied flavonoids, a quantitative structure-activity relationship (QSAR) analysis was performed"><entity charOffset="113-123" id="DDI-PubMed.24956178.s7.e0" text="flavonoids" /></sentence><sentence text=" This study showed that the size of the flavonoids was the most important factor inversely affecting their potencies"><entity charOffset="40-50" id="DDI-PubMed.24956178.s8.e0" text="flavonoids" /></sentence><sentence text=" The QSAR model can be used more broadly to predict the AO inhibitory activity of flavonoid-like structures for application in food-drug and drug-drug interaction studies"><entity charOffset="82-91" id="DDI-PubMed.24956178.s9.e0" text="flavonoid" /></sentence><sentence text=" " /></document>